Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis

Tofacitinib is an oral Janus kinase (JAK) inhibitor indicated for the treatment of rheumatoid arthritis (RA). The efficacy and safety/tolerability of tofacitinib have been extensively evaluated as monotherapy and combination therapy in multiple, randomised, multicentre studies in patients with RA. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertoldi, Ilaria, Caporali, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326925/
https://www.ncbi.nlm.nih.gov/pubmed/34349573
http://dx.doi.org/10.2147/OARRR.S322086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326925/
https://www.ncbi.nlm.nih.gov/pubmed/34349573
http://dx.doi.org/10.2147/OARRR.S322086

Ejemplares similares